Hang Chi Holdings Limited Stocks

HK$ 0.69Last Updated 04.03.2025

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

HK$ 35.24M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
HK$ 0.69
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Hang Chi Holdings Limited, an investment holding company, operates elderly residential care homes under the Shui On, Shui Hing, Shui Jun, and Guardian Home brand names in Hong Kong. The company offers residential care home services to elderly residents, including the provision of accommodation with dietician-managed meal plans, 24-hour nursing, and caretaking assistance, as well as professional services comprising regular medical consultation, physiotherapy, occupational therapy, psychological, and social care services. It also sells healthcare and medical consumable products, such as adult nappies, nutritional milk, other medical consumable products, and daily supplies; and provides customizable add-on healthcare services to the elderly residents. The company was incorporated in 2016 and is headquartered in Kowloon Bay, Hong Kong. Hang Chi Holdings Limited is a subsidiary of Shui Wah Limited.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks